#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Herpes simplex Congenital disorder of glycosylation Acute leukaemia X-linked lymphoproliferative syndrome Cardiac failure acute Congenital hypotransferrinaemia Immune-mediated renal disorder Pulmonary tuberculosis Congenital growth hormone deficiency Immune thrombocytopenia Follicular lymphoma stage I Congenital pseudarthrosis Pemphigus Pulmonary arterial hypertension Neuronal ceroid lipofuscinosis More trials…

    Learn about Rare Diseases

    Sarcoidosis – Diagnostics Acquired haemophilia Marginal zone lymphoma refractory – Life with Disease IgA nephropathy – Diagnostics Rhabdoid tumour – Life with Disease X-linked lymphoproliferative syndrome Retinoblastoma – Treatment Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Soft tissue sarcoma – Basic Information Progressive multifocal leukoencephalopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lutetium (177Lu) Oxodotreotide Bevacizumab Specific Nucleic Acid Sna-Xfsa Antithymocyte Immunoglobulin XYLOMETAZOLINE HYDROCHLORIDE Dexlansoprazole Temocillin Sodium Vaborbactam Mrna-3210 Cefaclor Nebivolol Hydrochloride Brexpiprazole Fumarate Trimetazidine Dihydrochloride Diclofenac Diethylamine Azetukalner Mcla-129 Fluasterone Bortezomib Immunoglobulin G Odm-111 More therapies…

    Learn about Your Condition

    Cytokine release syndrome Allergic respiratory disease Cutibacterium acnes infection Agitation Stress Retinitis pigmentosa Breast cancer female Monkeypox Rectosigmoid cancer Drug eruption Polycythaemia vera Small cell lung cancer Haemodynamic instability Strongyloidiasis Intestinal infarction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hippokrateslaan 10, Batiment 54, Woluwe-Saint-Lambert, 1200, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of JNJ-63733657 and Florquinitau F18 in Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Posdinemab
    Belgium France The Netherlands Spain Sweden

  • Study on the Safety and Effectiveness of 19CP02 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1
    Investigated Drugs:
    • 19Cp02
    Belgium Finland The Netherlands

  • Study on Tecovirimat for Treating Monkeypox in Patients with Confirmed Infection

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tecovirimat
    Belgium France Germany Italy The Netherlands Norway +2

  • Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Ibrutinib
    • Parsaclisib Hydrochloride
    • Ruxolitinib
    Belgium Czechia Denmark France Italy Poland +2

  • Study on the Safety and Effectiveness of BCMACP03 for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Bcmacp03
    Belgium The Netherlands

  • Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute hepatic failure
    • Hepatic cirrhosis
    • Inborn error of metabolism
    Investigated Drugs:
    • Hhalpc
    Belgium Bulgaria France Poland Spain

  • Study on the Safety and Effects of Ixodes ricinus Contact Phase Inhibitor in Adults with Spontaneous Brain Bleeding

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Ixodes Ricinus Contact Phase Inhibitor
    Belgium

  • Study Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Adalimumab
    • Upadacitinib
    Belgium Bulgaria Croatia Czechia Estonia France +11

  • Study of Vobramitamab Duocarmazine and Prednisone for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Vobramitamab Duocarmazine
    • Prednisone
    Belgium Czechia France Germany Italy Poland +1

  • Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Efanesoctocog Alfa
    Austria Belgium Croatia Czechia France Germany +8
Previous Page
1 … 59 60 61 62 63 … 67
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!